Theradiag SA said CEO Michel Finance will leave the company at the end of 2018.
The French medical device maker said the process to find Finance's replacement is already underway.
Theradiag develops and sells diagnosis kits that measure the efficiency of biotherapies in the treating autoimmune diseases and cancer.